Clinical Trial Advertising for Phase II Parkinson's Disease Study

February 9, 2018

Challenge

Enrollment for this 60-patient study had been underway for one year with 35 subjects enrolled. The sponsor had a 90-day deadline for randomizing the remaining 25 subjects.

Solution

ThreeWire worked with five carefully selected sites to identify a mix of “known” and “unknown” study candidates through chart reviews and highly targeted radio and print advertisements. All candidates were screened by our Patient Interaction Center® nurses. Those who passed pre-screening were invited with caregivers to attend a ThreeWire Community Health Talk®, where the respective investigator delivered a presentation base on informed consent. Interested participants were offered the opportunity for site screening.

Results

Following a 30-day startup period, 5 CHTs were conducted over a 10-day period. Out of a total of 75 attendees, 25 subjects were consented and randomized prior to the 90-day deadline.

Previous Flipbook
Patient Enrollment for Phase II Heart Failure Study
Patient Enrollment for Phase II Heart Failure Study

Next Flipbook
Trial Enrollment Advertising for Phase II Constipation Drug
Trial Enrollment Advertising for Phase II Constipation Drug

This study was open to enrollment for 4 months, but was significantly behind the projected enrollment plann...